
Riddhi Siddhi Gluco Biols Board Meeting on Nov 5 to Approve Q2 FY27 Results
Riddhi Siddhi Gluco Biols Ltd has announced that its Board of Directors will convene on November 5, 2026, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2026. The meeting will also involve adopting the Limited Review Reports from the Statutory Auditors. Concurrently, the trading window for designated persons and their relatives will remain closed until 48 hours after the declaration of these financial results, having been initially closed from October 1, 2026.
Key Highlights
- Board meeting scheduled for November 5, 2026.
- To approve Unaudited Financial Results for Q2 FY27.
- Limited Review Reports to be adopted.
- Trading window closure until 48 hours post-results.
Price Impact
More from RIDDHI
Riddhi Siddhi Gluco Biols: Board Approves Q2 FY27 Unaudited Financial Results
Riddhi Siddhi Q2 FY27: Core Ops Turn Profitable, but Consol PAT Falls 50% YoY to ₹6.85 Cr
Riddhi Siddhi Gluco Biols Closes Trading Window for Insider Trading